Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
MIST Milestone Pharmaceuticals Inc
- Stocks
- Healthcare
- NASDAQ: MIST
Price (delayed)
$1.65
Market cap
$88.22M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.78
Enterprise value
$98.72M
Milestone Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of etripamil, a Phase 3 clinical-stage program, for the treatment of cardiovascular indications. Milestone Pharmaceuticals operates in Canada
Highlights
The EPS is up by 38% YoY but it is down by 16% QoQ
The net income fell by 25% QoQ but it rose by 6% YoY
The company's equity has shrunk by 147% QoQ and by 115% YoY
MIST's quick ratio has plunged by 80% YoY and by 50% from the previous quarter
Key stats
What are the main financial stats of MIST
Market
Valuations
Earnings
Shares outstanding
53.46M
Market cap
$88.22M
Enterprise value
$98.72M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$52.15M
Net income
-$51.93M
EBIT
-$48.28M
EBITDA
-$48.18M
Free cash flow
-$33.91M
Per share
Balance sheet
Liquidity
EPS
-$0.78
EPS diluted
-$0.78
Free cash flow per share
-$0.51
Book value per share
-$0.11
Revenue per share
$0
TBVPS
$0.93
Total assets
$61.89M
Total liabilities
$68.01M
Debt
$55.59M
Equity
-$6.12M
Working capital
$47.51M
Debt to equity
-9.08
Current ratio
4.67
Quick ratio
4.41
Net debt/EBITDA
-0.22
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-67.1%
Return on equity
-329.6%
Return on invested capital
-48.3%
Return on capital employed
-98.7%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MIST stock price
How has the Milestone Pharmaceuticals stock price performed over time
Intraday
-2.37%
1 week
8.55%
1 month
25.95%
1 year
8.55%
YTD
-30.08%
QTD
106.22%
Financial performance
How have Milestone Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$52.15M
Net income
-$51.93M
Gross margin
N/A
Net margin
N/A
The net income fell by 25% QoQ but it rose by 6% YoY
The operating income has contracted by 24% from the previous quarter but it has grown by 7% YoY
Price vs fundamentals
How does MIST's price correlate with its fundamentals
Growth
What is Milestone Pharmaceuticals's growth rate over time
Valuation
What is Milestone Pharmaceuticals stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is up by 38% YoY but it is down by 16% QoQ
The company's equity has shrunk by 147% QoQ and by 115% YoY
Efficiency
How efficient is Milestone Pharmaceuticals business performance
Milestone Pharmaceuticals's return on equity has shrunk by 116% QoQ and by 88% YoY
The ROIC has shrunk by 51% QoQ and by 9% YoY
MIST's ROA is down by 39% QoQ and by 8% YoY
Dividends
What is MIST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MIST.
Financial health
How did Milestone Pharmaceuticals financials performed over time
The total assets is 9% smaller than the total liabilities
MIST's quick ratio has plunged by 80% YoY and by 50% from the previous quarter
The current ratio has plunged by 79% YoY and by 49% from the previous quarter
The company's equity has shrunk by 147% QoQ and by 115% YoY
MIST's debt is up by 6% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.